223 related articles for article (PubMed ID: 12089368)
1. Cardiac and renal effects of standard versus rigorous blood pressure control in autosomal-dominant polycystic kidney disease: results of a seven-year prospective randomized study.
Schrier R; McFann K; Johnson A; Chapman A; Edelstein C; Brosnahan G; Ecder T; Tison L
J Am Soc Nephrol; 2002 Jul; 13(7):1733-9. PubMed ID: 12089368
[TBL] [Abstract][Full Text] [Related]
2. Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease.
Zeltner R; Poliak R; Stiasny B; Schmieder RE; Schulze BD
Nephrol Dial Transplant; 2008 Feb; 23(2):573-9. PubMed ID: 17984104
[TBL] [Abstract][Full Text] [Related]
3. Reversal of left ventricular hypertrophy with angiotensin converting enzyme inhibition in hypertensive patients with autosomal dominant polycystic kidney disease.
Ecder T; Edelstein CL; Chapman AB; Johnson AM; Tison L; Gill EA; Brosnahan GM; Schrier RW
Nephrol Dial Transplant; 1999 May; 14(5):1113-6. PubMed ID: 10344347
[TBL] [Abstract][Full Text] [Related]
4. Effect of antihypertensive therapy on renal function and urinary albumin excretion in hypertensive patients with autosomal dominant polycystic kidney disease.
Ecder T; Chapman AB; Brosnahan GM; Edelstein CL; Johnson AM; Schrier RW
Am J Kidney Dis; 2000 Mar; 35(3):427-32. PubMed ID: 10692268
[TBL] [Abstract][Full Text] [Related]
5. Prospective change in renal volume and function in children with ADPKD.
Cadnapaphornchai MA; McFann K; Strain JD; Masoumi A; Schrier RW
Clin J Am Soc Nephrol; 2009 Apr; 4(4):820-9. PubMed ID: 19346430
[TBL] [Abstract][Full Text] [Related]
6. Early cardiovascular manifestations in children and adolescents with autosomal dominant polycystic kidney disease: a single center study.
Karava V; Benzouid C; Hogan J; Dossier C; Denjean AP; Deschênes G
Pediatr Nephrol; 2018 Sep; 33(9):1513-1521. PubMed ID: 29774463
[TBL] [Abstract][Full Text] [Related]
7. Left ventricular hypertrophy in hypertensive patients with autosomal dominant polycystic kidney disease: influence of blood pressure and humoral and neurohormonal factors.
Martinez-Vea A; Valero FA; Bardaji A; Gutierrez C; Broch M; Garcia C; Richart C; Oliver JA
Am J Nephrol; 2000; 20(3):193-200. PubMed ID: 10878400
[TBL] [Abstract][Full Text] [Related]
8. Cardiac magnetic resonance assessment of left ventricular mass in autosomal dominant polycystic kidney disease.
Perrone RD; Abebe KZ; Schrier RW; Chapman AB; Torres VE; Bost J; Kaya D; Miskulin DC; Steinman TI; Braun W; Winklhofer FT; Hogan MC; Rahbari-Oskoui F; Kelleher C; Masoumi A; Glockner J; Halin NJ; Martin D; Remer E; Patel N; Pedrosa I; Wetzel LH; Thompson PA; Miller JP; Bae KT; ; Meyers CM
Clin J Am Soc Nephrol; 2011 Oct; 6(10):2508-15. PubMed ID: 21903983
[TBL] [Abstract][Full Text] [Related]
9. Autosomal dominant polycystic kidney disease and hypertension are associated with left ventricular mass in a gender-dependent manner.
Pietrzak-Nowacka M; Safranow K; Czechowska M; Dutkiewicz G; Kornacewicz-Jach Z; Ciechanowski K
Kidney Blood Press Res; 2012; 36(1):301-9. PubMed ID: 23235185
[TBL] [Abstract][Full Text] [Related]
10. Morning blood pressure surge in early autosomal dominant polycystic kidney disease and its relation with left ventricular hypertrophy.
Yildiz A; Sag S; Gul CB; Güllülü S; Can FE; Bedir Ö; Aydin MF; Oruç A; Demirel S; Akgür S; Güllülü M; Ersoy A
Ren Fail; 2021 Dec; 43(1):223-230. PubMed ID: 33478355
[TBL] [Abstract][Full Text] [Related]
11. Left ventricular hypertrophy in a contemporary cohort of autosomal dominant polycystic kidney disease patients.
Chen H; Watnick T; Hong SN; Daly B; Li Y; Seliger SL
BMC Nephrol; 2019 Oct; 20(1):386. PubMed ID: 31653199
[TBL] [Abstract][Full Text] [Related]
12. Left ventricular hypertrophy in autosomal dominant polycystic kidney disease.
Chapman AB; Johnson AM; Rainguet S; Hossack K; Gabow P; Schrier RW
J Am Soc Nephrol; 1997 Aug; 8(8):1292-7. PubMed ID: 9259356
[TBL] [Abstract][Full Text] [Related]
13. Renal volume in children with ADPKD: size matters.
Chapman AB; Guay-Woodford LM
Clin J Am Soc Nephrol; 2009 Apr; 4(4):698-9. PubMed ID: 19339418
[No Abstract] [Full Text] [Related]
14. Effect of enalapril on blood pressure, renal function, and the renin-angiotensin-aldosterone system in cats with autosomal dominant polycystic kidney disease.
Miller RH; Lehmkuhl LB; Smeak DD; DiBartola SP; Radin J
Am J Vet Res; 1999 Dec; 60(12):1516-25. PubMed ID: 10622161
[TBL] [Abstract][Full Text] [Related]
15. Comparative effects of valsartan versus amlodipine on left ventricular mass and reactive oxygen species formation by monocytes in hypertensive patients with left ventricular hypertrophy.
Yasunari K; Maeda K; Watanabe T; Nakamura M; Yoshikawa J; Asada A
J Am Coll Cardiol; 2004 Jun; 43(11):2116-23. PubMed ID: 15172423
[TBL] [Abstract][Full Text] [Related]
16. Renal volume, renin-angiotensin-aldosterone system, hypertension, and left ventricular hypertrophy in patients with autosomal dominant polycystic kidney disease.
Schrier RW
J Am Soc Nephrol; 2009 Sep; 20(9):1888-93. PubMed ID: 19696226
[TBL] [Abstract][Full Text] [Related]
17. No effect of enalapril on progression in autosomal dominant polycystic kidney disease.
van Dijk MA; Breuning MH; Duiser R; van Es LA; Westendorp RG
Nephrol Dial Transplant; 2003 Nov; 18(11):2314-20. PubMed ID: 14551359
[TBL] [Abstract][Full Text] [Related]
18. A comparison of the effects of ramipril and losartan on blood pressure control and left ventricle hypertrophy in patients with autosomal dominant polycystic kidney disease.
Ulusoy S; Ozkan G; Orem C; Kaynar K; Koşucu P; Kiriş A
Ren Fail; 2010; 32(8):913-7. PubMed ID: 20722556
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular manifestations of autosomal dominant polycystic kidney disease in young adults.
Handa SP
Clin Invest Med; 2006 Dec; 29(6):339-46. PubMed ID: 17330449
[TBL] [Abstract][Full Text] [Related]
20. Cardiac involvement in autosomal-dominant polycystic kidney disease: a hypertensive heart disease.
Bardají A; Martinez-Vea A; Valero A; Gutierrez C; Garcia C; Ridao C; Oliver JA; Richart C
Clin Nephrol; 2001 Sep; 56(3):211-20. PubMed ID: 11597036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
